Calibration and validation of an oral fluid-based sensitive/less-sensitive assay to distinguish recent from established HIV-1 infections

Journal of Clinical Laboratory Analysis

Volumn 21, Issue 1, 2007, Pages 40-45

  Sill, Anne M ^a   Kreisel, Kristen ^a   Deeds, Bethany Griffin ^a   Wilson, Craig M ^b,c   Constantine, Niel T ^a   Peralta, Ligia ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b University of Alabama at Birmingham   (United States)

^c University of Alabama at Birmingham   (United States)

Author keywords

Adolescents; HIV; Incidence; S LS; Saliva

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ENZYME IMMUNOASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; OPTICAL DENSITY; REPRODUCIBILITY; ROC CURVE; SALIVA ANALYSIS; SCHOOL CHILD; SEROCONVERSION; VALIDATION PROCESS; VEIN PUNCTURE; CALIBRATION; CHILD; FEMALE; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; MALE; SALIVA; SENSITIVITY AND SPECIFICITY; SERUM; STANDARD; VALIDATION STUDY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; CALIBRATION; CHILD; FEMALE; HIV ANTIBODIES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; REPRODUCIBILITY OF RESULTS; SALIVA; SENSITIVITY AND SPECIFICITY; SERUM;

EID: 34047234226     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.20144     Document Type: Article

References (11)

1. Constantine NT, Zink H. HIV testing technologies after two decades of evolution. Indian J Med Res 2005;121:519-538.
2. Dobbs T, Parekh BS. Detecting recent human immunodeficiency virus type 1 infection: why and how? MLO Med Lab Obs 2003; 35:12-14, 16, 19-20 passim; quiz 24-25.
3. Rutherford GW, Schwarcz SK, McFarland W. Surveillance for incident HIV infection: new technology and new opportunities. J Acquir Immune Defic Syndr 2000;25(Suppl 2):S115-S119.
4. Janssen RS, Satten GA, Stramer SL, et al. New testing strategy to detect early HIV-1 infection for use in incidence estimates and for clinical and prevention purposes. JAMA 1998;280:42-48.
5. UNAIDS Reference Group on Estimates, Modeling and Projections statement on the use of the BED-assay for the estimation of HIV-1 incidence for surveillance or epidemic monitoring 2005. 〈www.epidem.org/Publications/ BED%20statement.pdf〉
6. Constantine NT, Sill AM, Cleghorn FR, et al. Improved classification of recent HIV-1 infection by employing a two-stage sensitive/ less-sensitive test strategy. J Acquir Immune Defic Syndr 2003;32: 94-103.
7. Constantine NT, Saville R, Dax EM. Retroviral testing and quality assurance: essentials for laboratory diagnosis. Ann Arbor: Malloy. 2005. Malloy Printers, ISBN: 0-9785982-0-2;2005.
8. Peralta L, Constantine N, Griffin-Deeds B, Martin L, Ghalib K. Evaluation of youth preferences for rapid and innovative human immunodeficiency virus antibody tests. Arch Pediatr Adolesc Med 2001;155:838-843.
9. Rawal BD, Degula A, Lebedeva L, et al. Development of a new less-sensitive enzyme immunoassay for detection of early HIV-1 infection. J Acquir Immune Defic Syndr 2003;33: 349-355.
10. Kothe D, Byers RH, Caudill SP, et al. Performance characteristics of a new less sensitive HIV-1 enzyme immunoassay for use in estimating HIV seroincidence. J Acquir Immune Defic Syndr 2003;33:625-634.
11. Begg CB. Statistical methods in medical diagnosis. CRC Crit Rev Med Inform 1986;1:1-22.